Page last updated: 2024-10-27

2,5-dihydroxybenzoic acid and Fatty Liver with Encephalopathy

2,5-dihydroxybenzoic acid has been researched along with Fatty Liver with Encephalopathy in 1 studies

2,5-dihydroxybenzoic acid: RN given refers to parent cpd; a oxidative product of saligenin
2,5-dihydroxybenzoic acid : A dihydroxybenzoic acid having the two hydroxy groups at the 2- and 5-positions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meert, KL1
Kauffman, RE1
Deshmukh, DR1
Sarnaik, AP1

Other Studies

1 other study available for 2,5-dihydroxybenzoic acid and Fatty Liver with Encephalopathy

ArticleYear
Impaired oxidative metabolism of salicylate in Reye's syndrome.
    Developmental pharmacology and therapeutics, 1990, Volume: 15, Issue:2

    Topics: Arthritis, Juvenile; Biotransformation; Gentisates; Humans; Hydroxybenzoates; Oxidation-Reduction; R

1990